Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
J Am Soc Nephrol 14:A9-A11, 2003
© 2003 American Society of Nephrology

This Month's Highlights

Molecular Medicine and Genetics

Genotype-Renal Function Correlation in Type 2 Autosomal Dominant Polycystic Kidney Disease
Effects of PKD2 Mutations on the Severity of Polycystic Kidney Disease.
Go

Autosomal dominant polycystic kidney disease (ADPKD), the most common renal genetic disorder, is caused by mutations of PKD1 or PKD2. Mutations of PKD2 account for 15% of cases and produce a disease that is later in onset but otherwise phenotypically identical to the disease caused by mutations of PKD1. In this issue, Magistroni et al. report the largest genotype-phenotype correlation that has been performed for PKD2. They studied 461 affected individuals from 71 families with PKD2 mutations. Their major findings were that 40% of individuals had chronic renal failure or end-stage renal disease (ESRD), mean age of onset of ESRD was 72 years, and female patients developed ESRD 8 years later than male patients. Unlike a previous study, the location of the mutation in the gene did not affect disease severity. However, splice site mutations produced a milder disease compared with other types of mutations. The considerable variability in disease among individuals with the same mutation indicates that disease severity is heavily influenced by additional genetic and/or environmental factors.

Hematopoietic Stem Cells Contribute to the Regeneration of Renal Tubules after Renal Ischemia-Reperfusion Injury in Mice
Beyond Dopamine and Lasix? Hematopoietic Stem Cells Repopulate Necrotic Tubules with New Tubular Cells.
Go

Despite its frequency as a clinical problem requiring nephrology consultation, the incidence and outcome of acute renal failure (ARF) from ischemic acute tubular necrosis (ATN) have remained constant for decades. This is not for lack of research on the topic; indeed, major advances have been made in understanding the roles of various hemodynamic processes, apoptosis, oxidant injury, growth factors, etc. in regulating tubular cell death and regeneration. None of these have yet led to successful clinical interventions. In this issue, Lin et al. report an entirely new approach to ATN. Using sophisticated molecular genetics and marking technology, they harvested male hematopoietic stem cells and infused them into female recipients with unilateral ATN. The results are dramatic. Illustrations show the donor stem cells later lining the walls of necrotic proximal tubules and also acquiring and expressing markers of healthy proximal tubular cells. The article does not report functional data to document improved tubular or kidney function, but the fact that the stem cells repopulated injured tubules and became tubular cells is enough for now. This article is an exciting illustration of the potential applications for stem cell therapy in renal diseases. Stay tuned — there will be a lot more to come in this area.

Pathophysiology of Renal Disease

Focal and Segmental Glomerulosclerosis in Mice with Podocyte-Specific Expression of Mutant {alpha}-Actinin-4
A New Mouse Model of Inherited FSGS.
Go

Focal and segmental glomerulosclerosis (FSGS) is a major cause of renal failure that is increasing in frequency. Most cases are sporadic and of unknown etiology, but inherited forms of FSGS have also been described. {alpha}-Actinin-4 is a cytoskeletal protein that is mutated in humans with a rare autosomal dominant form of FSGS. Michaud et al. expressed a mutant form of {alpha}-actinin-4 in transgenic mice using a podocyte-specific promoter from the nephrin gene. Mutant transgenic mice exhibited proteinuria, elevated blood pressure, and renal histologic findings of FSGS. Moreover, the expression of nephrin, a component of the glomerular slit diaphragm, was markedly reduced. These studies confirm that mutations of {alpha}-actinin-4 cause FSGS and indicate that the actin cytoskeleton is required to maintain the integrity of the slit diaphragm complex. {alpha}-Actinin-4 transgenic mice represent the first mouse model of inherited human FSGS and should be useful for further exploration of the pathogenesis and treatment of familial as well as sporadic forms of the disease.

Mineral Metabolism and Bone Disease

Menopause and Postmenopausal Hormone Use and Risk of Incident Kidney Stones
Bones, Stones, and Hormones: Another Insight into the Factors that Regulate Stone Formation in Women.
Go

It has been recognized for some time that women are at decreased risk of kidney stones. The protective effect of gender is associated with lower urinary calcium excretion, and it has been suggested that estrogen may contribute to this protection against kidney stone formation. Mattix-Kramer et al. examined the protective role of estrogen in the prospective Nurses’ Health cohort study of over 121,000 women. They report a higher risk among women experiencing surgical, but not age-related, menopause and that these associations persist after accounting for hormone replacement therapy. These observations suggest either that the rapidity of increased calcium loss from bone after surgical menopause increases the risk of kidney stones compared with women experiencing age-related menopause or that other non-estrogen effects of surgical menopause are responsible for the differences in risk. These factors might include loss of androgen production from the removed ovaries, increased excretion of stone-promoting factors, or changes in urine inhibitory activity toward crystal aggregation.

Clinical Nephrology

Broadening the Spectrum of Diseases Related to Podocin Mutations
Frequent Occurrence of Podocin Mutations in Children with Nephrotic Syndrome.
Go

Podocin is an integral membrane protein that is located in the foot processes of glomerular epithelial cells. Mutations of the podocin gene (NPHS2) have been identified in humans with familial and sporadic forms of steroid-resistant nephrotic syndrome. Caridi et al. screened for podocin mutations in 135 children presenting with sporadic steroid-resistant or steroid-sensitive nephrotic syndrome. Overall, homozygous podocin mutations were identified in 12% of children with steroid-resistant nephrotic syndrome. Single podocin mutations were identified in eight patients, five of whom presented with drug-sensitive disease. Although the possibility that the second mutation was not detected cannot be excluded, these results raise the possibility that heterozygous podocin mutations may also predispose to nephrotic syndrome, perhaps in conjunction with mutations of other glomerular proteins, such as nephrin. This study verifies that podocin mutations are a common cause of sporadic nephrotic syndrome, and it expands the spectrum of patients to include those with steroid-sensitive disease.

Dialysis

Determinants of Survival among HIV-Infected Chronic Dialysis Patients
Survival of HIV-Infected Chronic Dialysis Patients.
Go

The dramatic improvement in survival of HIV-infected patients with use of highly active antiretroviral therapy (HAART) has not occurred among HIV-infected patients initiating dialysis. The median survival of all HIV-infected patients in San Francisco with an opportunistic infection increased from 16 months in 1995 to 81 months in 1996. Among 115 patients with HIV initiating dialysis at the San Francisco General Hospital, there was an increase in median survival from 9.4 to 16.1 months between the pre-HAART and the HARRT era. Factors associated with improved survival were higher CD4 counts (hazard ratio [HR], 0.86 per 50 cells/mm3 increase) and higher serum albumin (HR, 0.53 per 1 g/dl increase) at initiation. The poorer survival may be partly explained by a higher proportion of African-American patients, injection drug use, and hepatitis C co-infection. However, only 33% of patients initiating dialysis during the HAART era were receiving this therapy. Factors associated with under-utilization of HARRT therapy in this population should be targeted for correction.

Epidemiology and Outcomes

Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women
Can the Increased Risk of Cardiovascular Disease in Men Be Explained by Differences in Urinary Albumin Excretion between Men and Women?
Go

The discrepancy in risk of atherosclerotic cardiovascular disease between men and women cannot be fully explained by gender-specific differences in prevalence of traditional risk factors. Urinary albumin excretion (UAE) is a new cardiovascular risk factor. In this issue of JASN, Verhave et al. report that UAE is associated with the level of several cardiovascular risk factors and is higher among men compared with women. They further noted that the UAE was greater among men at each risk factor level and that this interaction persisted after controlling for the joint effects of relevant risk factors. These observations suggest that male patients may be more susceptible to endothelial injury if UAE is a marker of impaired endothelial function. Other interpretations of these observations include the possibility that gender-related differences in renal injury may account for the increased UAE seen in men and may also contribute to increased risk of CVD through mechanisms, such as increased systemic oxidative stress, that do not involve endothelial function. It is also possible that the increased UAE noted by Verhave et al. may also reflect gender differences in the existing burden of preclinical atherosclerosis, which is linked in well-defined mechanisms to increased risk of glomerulotubular injury. These observations contribute to the growing need to better define the nexus between proteinuria and other cardiovascular risk factors in the pathogenesis of atherosclerotic cardiovascular disease and progressive renal injury.

Transplantation

Normal Human Kidney HLA-DR–Expressing Renal Microvascular Endothelial Cells: Characterization, Isolation, and Regulation of MHC Class II Expression
Another Role for Statins in the Kidney: Regulation of HLA-DR Antigen Expression and Possibly T Cell–Mediated Inflammation.
Go

HLA-DR initiates CD4 T cell responses by presenting bound antigen to specific T cell receptors in the presence of co-stimulatory molecules. In normal human kidney, HLA-DR is abundantly expressed on renal microvascular endothelial cells (RMEC) of peritubular and glomerular capillaries. It is therefore available to circulating T cells and may impart a surveillance capacity for initiation of inflammatory responses, including transplant rejection. Using multi-laser flow cytometry to identify cells in a standard renal biopsy, Muczynski et al. show that normal RMEC obtained from renal biopsies express HLA-DR but lack the co-stimulatory molecules required to prime naïve T cells (CD80 and CD86). However, they do express the co-stimulatory molecules that enhance sensitized T cell activation (CD40 and CD58). Thus RMEC HLA-DR may facilitate anergy in naïve T cells but intensify primed T cell responses. They also show that RMEC HLA-DR expression, which in vitro requires normal physiologic concentrations of {gamma}-interferon, is under the control of a statin-sensitive transcription factor. HLA-DR expression and associated T cell responses may therefore be amenable to regulation with statins.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP